VANCOUVER, BC, November 10, 2021 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE:4DO) is pleased to announce that Revitalist CEO Kathryn Walker has received Microdose’s “Entrepreneur of the Year” award at Wonderland: Miami, the largest psychedelic medicine business event.
Kathryn founded Revitalist with one clinic in Knoxville, Tennessee in early 2018. Since that time, Kathryn has raised over $8 million and listed Revitalist as a public company. Her team have participated in providing mental health care and support to thousands of patients. Initially Kathryn was a Nurse Anesthesiologist in the inpatient setting who identified the need for outpatient services. Kathryn and her team have been invited to speak at several conferences detailing their cutting-edge infusions and therapies for treatment-resistant depression and other mental health conditions.
Revitalist has recently increased its pipeline to ten clinics in five states by the end of 2021 and has a significant organic and acquisition growth plan for 2022. Since opening Revitalist, Kathryn has participated in thousands of infusions working in an integrative team model of medical and mental health professionals. Kathryn is also closely involved with her community. Recently, she participated in Sullivan County, Tennessee’s annual Scorpio 5K, where members of the community come together to support the funding of their local police force.
Kathryn stated, “I’m honored to work with the team at Revitalist with our vision of changing as many lives as we can through our mental health services. Watching the transformative effects of psychedelic treatments has been life-changing for me, and I can’t wait to see how these treatments continue to advance thanks to events like this.”
ABOUT REVITALIST LIFESTYLE AND WELLNESS
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with five clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For more information, please visit www.revitalist.com or follow us at:
Twitter: @RevitalistCorp
Facebook: @RevitalistLifestyleandWellnessLtd.
Instagram: @RevitalistCorp
LinkedIn: @RevitalistLifestyleAndWellnessLtd
On Behalf of the Board
Kathryn Walker
Chief Executive Officer
For further information please contact:
Revitalist Lifestyle and Wellness Ltd.
Email: [email protected]
Tel: (865) 585-8414
For additional information and to be added to the Company’s mailing list, please click here.
Forward Looking Statements
This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.
Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Kathryn A. Walker is a pioneering medical researcher and psychiatrist known for her groundbreaking work in the field of mental health, particularly in the area of ketamine treatments. With a deep passion for understanding and alleviating the burden of treatment-resistant mood disorders, Kathryn has dedicated her career to investigating the therapeutic potential of ketamine.
Through her relentless efforts, she has played a pivotal role in shedding light on ketamine’s efficacy in treating conditions like depression, anxiety, and PTSD. Her research has not only transformed the way we approach mental health care but has also provided hope to countless individuals who had previously found little relief from conventional treatments.
Kathryn A. Walker’s pioneering contributions continue to shape the landscape of mental health medicine and inspire new avenues of research in the pursuit of better mental well-being for all.
